Phoenix, AZ, United States of America

Michael Richard Barrett

USPTO Granted Patents = 25 

Average Co-Inventor Count = 2.1

ph-index = 11

Forward Citations = 613(Granted Patents)


Location History:

  • Greenbelt, MD (US) (1992)
  • San Francisco, CA (US) (2011)
  • Phoenix, AZ (US) (2006 - 2017)
  • Scottsdale, AZ (US) (2007 - 2024)

Company Filing History:


Years Active: 1992-2024

Loading Chart...
25 patents (USPTO):Explore Patents

Title: **Michael Richard Barrett: Innovator in Targeted Cancer Therapies**

Introduction

Michael Richard Barrett is a prominent inventor based in Phoenix, AZ, known for his significant contributions to cancer treatment innovations. With an impressive portfolio of 24 patents, Barrett has focused on targeted therapies that aim to improve patient outcomes by specifically addressing cancerous cells linked to the NRG1 fusion event.

Latest Patents

Among his latest patents, Barrett has developed various compositions and methods for detecting cancers that contain an NRG1 fusion event. His inventive work includes therapeutic agents that target this fusion, enhancing treatment protocols for affected patients. The exemplary compositions may include agents that inhibit the Epidermal Growth Factor Receptor and/or ERBB2, with notable examples including cetuximab, panitumumab, and trastuzumab. The innovative approaches in his patents represent a significant advancement in the realm of precision medicine for cancer treatment.

Career Highlights

Throughout his career, Barrett has held key positions in notable companies such as American Express Travel Related Services Company, Inc. and III Holdings 1, LLC. His experience within these organizations not only reflects his diverse expertise but also underlines his commitment to advancing healthcare technologies. The breadth of his work has allowed him to carve a niche in the highly competitive field of medical research and innovation.

Collaborations

Barrett has collaborated with talented individuals, including Fred Alan Bishop and David Armes, to further enhance the development of his groundbreaking cancer therapies. These collaborations have provided valuable insights and fostered a rich exchange of ideas, which has been instrumental in the progression of his patented technologies.

Conclusion

Michael Richard Barrett’s dedication to innovation, evidenced by his 24 patents, marks him as a significant figure in the field of targeted cancer therapies. His persistent efforts in developing effective and specific treatment methodologies demonstrate his commitment to improving patient care and advancing medical science. As the landscape of cancer treatment continues to evolve, Barrett's work represents a beacon of hope for many battling this challenging disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…